Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T43206 Target Info
Target Name Nuclear receptor ROR-alpha (RORA)
Synonyms Retinoid-related orphan receptor-alpha; Retinoic acid-related orphan receptor alpha; RZRA; RAR-related orphan receptor A; Nuclear receptor subfamily 1 group F member 1; Nuclear receptor RZR-alpha; NR1F1
Target Type Preclinical Target
Gene Name RORA
Biochemical Class Nuclear hormone receptor
UniProt ID
RORA_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US9598431
Title Compounds useful for inhibiting ROR-gamma-t
Abstract The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof:
Applicant(s) Eli Lilly and Company
Representative Drug(s) D0SK3V Drug Info N.A. [1]
Patent ID US9598431
Title Compounds useful for inhibiting ROR-gamma-t
Abstract The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof:
Applicant(s) Eli Lilly and Company
Representative Drug(s) D0SK3V Drug Info N.A. [1]
Patent ID US9598431
Title Compounds useful for inhibiting ROR-gamma-t
Abstract The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof:
Applicant(s) Eli Lilly and Company
Representative Drug(s) D0SK3V Drug Info N.A. [1]
Patent ID US9598431
Title Compounds useful for inhibiting ROR-gamma-t
Abstract The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof:
Applicant(s) Eli Lilly and Company
Representative Drug(s) D0SK3V Drug Info N.A. [1]
References  Top
REF 1 Compounds useful for inhibiting ROR-gamma-t. US9598431.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.